FDA
Biotech

AACR: Pazdur bemoans state of FDA, warns of political influence

Asked by Fierce if he'd consider returning to the FDA, Pazdur said he wouldn't serve again under the Trump administration "for obvious reasons."
Darren Incorvaia Apr 18, 2026 4:00am
sickle cell disease

Novo Nordisk readies SCD drug for approval push after ph. 3 win

Apr 20, 2026 8:33am
3 bioprocessing trendsand the critical enabler thats quietly driving them

3 bioprocessing trends—and the critical enabler that’s quietly driving them

Brought to you by Savillex
Lung

AstraZeneca’s faith in IL-33 blocker pays off with new ph. 3 win

Apr 20, 2026 7:22am
Yu Lu-Fierce Biotechjpg

How WuXi AppTec’s Integrated Platform Is Helping Therapies Move Faster from Discovery to Patients

Brought to you by WuXi AppTec
Odyssey boat greece

Odyssey charts new voyage to Nasdaq after false start last year

Apr 20, 2026 7:19am
More News

Agenus focuses on survival data as trial flops with no responses

Apr 20, 2026 5:53am

Trump orders FDA to fast-track reviews of psychedelic drugs

Apr 20, 2026 5:30am

AACR: Genentech veteran engineers ‘smart’ cancer drug startup

Apr 19, 2026 6:05pm

FDA celebrates animal testing shift as experts eye road ahead

Apr 19, 2026 6:00pm